相关实验视频

Updated: Sep 9, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

TCEAL2的表达是一种新的预后生物标志物,也是宫状细胞癌和宫腺癌的潜在治疗标

Jinyuan Li¹, Zhen Ye², Yuhong Gan³

¹Pelvic Radiotherapy Department, Meizhou People's Hospital, Meizhou, 514031, Guangdong, China.

Current medicinal chemistry

|August 28, 2025

概括

TCEAL2 是子宫癌 (CESC) 的潜在生物标志物. 较高的TCEAL2水平与治疗结果差,影响治疗敏感性相关,这表明它在癌症进展中的作用.

科学领域:

癌症学
分子生物学
基因组学

背景情况:

子宫皮细胞癌和子宫内腺癌 (CESC) 是严重的妇科恶性瘤,存活率较低.
目前对CESC的治疗有效性有限,需要确定新的生物标志物和治疗点.
改善患者的预后和实现个性化治疗策略是管理CESC的关键目标.

研究的目的:

研究TCEAL2表达在子宫癌 (CESC) 的作用.
评估TCEAL2作为潜在的预后生物标志物和CESC的治疗目标.
探索TCEAL2与CESC中的临床特征,预后和瘤微环境的相关性.

主要方法:

从多种癌症类型的癌症基因组图谱 (TCGA) 中分析TCEAL2表达数据,重点是CESC.
探索TCEAL2表达和临床参数,预后,免疫透,微卫星不稳定性 (MSI) 和mRNA稳定性 (mRNAsi) 之间的相关性.
在独立数据集 (GSE9750) 和CESC细胞系中使用定量实时PCR (qRT-PCR) 验证TCEAL2表达.

主要成果:

在CESC中,TCEAL2表达显著改变,并与先进的病理M阶段和初始治疗失败有关.
提升的TCEAL2水平与总生存率 (OS) 的降低相关,并作为不利的OS的独立预测指标.
TCEAL2表达与关键信号通路 (,氧化酸化,Wnt) 相关,与免疫细胞透,MSI,mRNAsi以及对特定药物的敏感性相反.

结论:

在CESC的进展中,TCEAL2发挥着重要作用,并影响瘤的微环境.
由于TCEAL2与免疫透和药物敏感性相关,它成为CESC的潜在预后生物标志物和治疗点.
需要进一步的研究来阐明TCEAL2的分子机制,并验证其在CESC管理中的临床实用性.

关键词:

子宫状细胞癌和子宫内腺癌在 TCEAL 对药物的敏感性.免疫透在 mRNAsi 预后情况

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol

Published on: April 4, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...